Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2021 Financial Results
15 oct. 2021 16h36 HE
|
Cryo-Cell International, Inc.
OLDSMAR, Fla., Oct. 15, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world’s first private cord blood bank to separate and store...
Insights on the Cell Therapy Consumables Global Market to 2031 - Industry Trends and Forecasts
12 oct. 2021 06h53 HE
|
Research and Markets
Dublin, Oct. 12, 2021 (GLOBE NEWSWIRE) -- The "Cell Therapy Consumables Market by Type of Consumable, Type of Cell Therapy, Scale of Operation, Type of End-User and Key Geographical Regions:...
Cryo-Cell International Announces Changes To Its Board of Directors
20 sept. 2021 18h05 HE
|
Cryo-Cell International, Inc.
MIAMI, Sept. 20, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (Nasdaq:CCEL), the leader in cord blood and cord tissue cryopreservation services, announces the appointment of Mr. Mark...
Global Cell Therapy Market Opportunity: USD 45 Billion+ By 2028
06 sept. 2021 04h23 HE
|
Research and Markets
Dublin, Sept. 06, 2021 (GLOBE NEWSWIRE) -- The "Global Cell Therapy Market Outlook, Patent & Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.com's offering. In last...
Cryo-Cell International Announces Uplisting to The Nasdaq Capital Market
30 août 2021 09h00 HE
|
Cryo-Cell International, Inc.
Cryo-Cell International, Inc. (Symbol CCEL), The Leader In Cord Blood And Cord Tissue Cryopreservation Services, Today Announced That The Company’s Common Stock Has Been Approved For Listing On The...
Rubius Therapeutics Appoints Jim Jogerst as Chief Business Officer
30 août 2021 08h00 HE
|
Rubius Therapeutics
CAMBRIDGE Mass., Aug. 30, 2021 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq: RUBY), a clinical-stage biopharmaceutical company that is genetically engineering red blood cells to create an...
Cryo-Cell International Completes Acquisition of Real Estate Property for Its Institute for Cellular Therapies
20 août 2021 09h04 HE
|
Cryo-Cell International, Inc.
Cryo-Cell International (symbol: CCEL) Purchases Real Estate Location for its Institute for Cellular Therapies in the Raleigh-Durham area. MIAMI, Aug. 20, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell...
Cryo-Cell International to Present at the Q3 Virtual Investor Summit
11 août 2021 09h00 HE
|
Cryo-Cell International, Inc.
MIAMI, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell International announces that Chairman of the Board and Co-CEO, David Portnoy, will be presenting at the Q3 Virtual Investor Summit on August 18th,...
Outlook on the Cell Therapy Manufacturing Global Market to 2030 - Industry Trends and Forecasts
11 août 2021 07h48 HE
|
Research and Markets
Dublin, Aug. 11, 2021 (GLOBE NEWSWIRE) -- The "Cell Therapy Manufacturing Market by Type of Cell Manufactured, Source of Cell, Scale of Operation, Purpose of Manufacturing and Key Geographical...
Asia-Pacific Cell Therapy Market Analysis 2021-2028 - Need for Development of New Therapies Against SARS-CoV-2 Presents Lucrative Opportunities
04 août 2021 10h13 HE
|
Research and Markets
Dublin, Aug. 04, 2021 (GLOBE NEWSWIRE) -- The "Asia Pacific Cell Therapy Market Size, Share & Trends Analysis Report by Use-type (Clinical-use, Research-use), by Therapy Type (Autologous,...